<VariationArchive VariationID="3043" VariationName="NM_000051.3(ATM):c.2839-579_2839-576del" VariationType="Deletion" Accession="VCV000003043" Version="21" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-06-23" DateCreated="2015-07-05" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18082" VariationID="3043">
      <GeneList>
        <Gene Symbol="ATM" FullName="ATM serine/threonine kinase" GeneID="472" HGNC_ID="HGNC:795" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108223067" stop="108369102" display_start="108223067" display_stop="108369102" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108093558" stop="108239825" display_start="108093558" display_stop="108239825" Strand="+" />
          </Location>
          <OMIM>607585</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000051.3(ATM):c.2839-579_2839-576del</Name>
      <CanonicalSPDI>NC_000011.10:108270482:GTAAGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108270483" stop="108270486" display_start="108270483" display_stop="108270486" variantLength="4" positionVCF="108270482" referenceAlleleVCF="GGTAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108141210" stop="108141213" display_start="108141210" display_stop="108141213" variantLength="4" positionVCF="108141209" referenceAlleleVCF="GGTAA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.108270485_108270488del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.108270485_108270488del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.108141212_108141215del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.108141212_108141215del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009830.1" sequenceAccession="NG_009830" sequenceVersion="1" change="g.52654_52657del">
            <Expression>NG_009830.1:g.52654_52657del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351834.2" sequenceAccession="NM_001351834" sequenceVersion="2" change="c.2839-579_2839-576del">
            <Expression>NM_001351834.2:c.2839-579_2839-576del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000051.4" sequenceAccession="NM_000051" sequenceVersion="4" change="c.2839-579_2839-576del" MANESelect="true">
            <Expression>NM_000051.4:c.2839-579_2839-576del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_135" sequenceAccession="LRG_135">
            <Expression>LRG_135:g.52654_52657del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_135t1" sequenceAccession="LRG_135t1">
            <Expression>LRG_135t1:c.2839-579_2839-576del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000051.3" sequenceAccession="NM_000051" sequenceVersion="3" change="c.2839-579_2839-576delAAGT">
            <Expression>NM_000051.3:c.2839-579_2839-576delAAGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252541" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607585.0026" DB="OMIM" />
        <XRef Type="rs" ID="587776552" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11889466 to determine the location of this deletion on the current reference sequence. The 4-nt intronic deletion in IVS18 (IVS20 in PubMed 11889466) causes the activation of a cryptic 65-nt exon in gene ATM.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000051.3(ATM):c.2839-579_2839-576del AND Ataxia-telangiectasia syndrome" Accession="RCV000003184" Version="12">
        <ClassifiedConditionList TraitSetID="770">
          <ClassifiedCondition DB="MedGen" ID="C0004135">Ataxia-telangiectasia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-05-21" SubmissionCount="5">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000051.3(ATM):c.2839-579_2839-576del AND Familial cancer of breast" Accession="RCV003137487" Version="3">
        <ClassifiedConditionList TraitSetID="774">
          <ClassifiedCondition DB="MedGen" ID="C0346153">Familial cancer of breast</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-14" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000051.3(ATM):c.2839-579_2839-576del AND Hereditary cancer-predisposing syndrome" Accession="RCV001016574" Version="6">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-07" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000051.3(ATM):c.2839-579_2839-576del AND not provided" Accession="RCV001557139" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-21" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2015-07-05" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11889466</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12815592</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14695534</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19773425</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22213089</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31611883</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9887333</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-08-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-08-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="770" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4635" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia, complementation group D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AT, COMPLEMENTATION GROUP C</ElementValue>
                <XRef ID="208900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA-TELANGIECTASIA, COMPLEMENTATION GROUP A</ElementValue>
                <XRef Type="Allelic variant" ID="607585.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA-TELANGIECTASIA, FRESNO VARIANT</ElementValue>
                <XRef Type="Allelic variant" ID="607585.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Louis-Bar syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebello-oculocutaneous telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with ataxia telangiectasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia-telangiectasia syndrome</ElementValue>
                <XRef ID="Ataxia+Telangiectasia/637" DB="Genetic Alliance" />
                <XRef ID="68504005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia, complementation group E</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AT</ElementValue>
                <XRef Type="MIM" ID="208900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">A-T</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATM</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATE</ElementValue>
                <XRef ID="208900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATC</ElementValue>
                <XRef ID="208900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATA</ElementValue>
                <XRef ID="208900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATD</ElementValue>
                <XRef ID="208900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AT1</ElementValue>
                <XRef Type="MIM" ID="208900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic ataxia-telangiectasia (A-T) is characterized by progressive cerebellar ataxia beginning between ages one and four years, oculomotor apraxia, choreoathetosis, telangiectasias of the conjunctivae, immunodeficiency, frequent infections, and an increased risk for malignancy, particularly leukemia and lymphoma. Individuals with A-T are unusually sensitive to ionizing radiation. Non-classic forms of A-T have included adult-onset A-T and A-T with early-onset dystonia.</Attribute>
                <XRef ID="NBK26468" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5862" />
                <XRef ID="5862" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301790</ID>
                <ID Source="BookShelf">NBK26468</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="100" DB="Orphanet" />
              <XRef ID="C0004135" DB="MedGen" />
              <XRef ID="MONDO:0008840" DB="MONDO" />
              <XRef Type="MIM" ID="208900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="774" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="536" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial cancer of breast</ElementValue>
                <XRef ID="Familial+cancer+of+breast/8375" DB="Genetic Alliance" />
                <XRef ID="254843006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Breast cancer, familial</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (including fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The risk of developing an associated cancer varies depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.</Attribute>
                <XRef ID="NBK1247" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17142" />
                <XRef ID="17142" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561700" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000531340" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591268" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530707" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562228" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301425</ID>
                <ID Source="BookShelf">NBK1247</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="review" Abbrev="Stratton and Rahman, 2008">
                <ID Source="PubMed">18163131</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2007">
                <ID Source="PubMed">17508274</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2014 [Archived]">
                <ID Source="PubMed">24366376</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2014">
                <ID Source="PubMed">24366402</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="USPSTF, 2013">
                <ID Source="PubMed">24432435</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/guidelines/guidelines-detail?category=1&amp;id=1419</URL>
                <CitationText>Breast Cancer, NCCN Guidelines Version 4.2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2022">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version 2.2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="St. Gallen, 2021">
                <ID Source="PubMed">34242744</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2019">
                <ID Source="PubMed">31429903</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="USPSTF, 2019">
                <ID Source="PubMed">31479213</ID>
                <ID Source="BookShelf">NBK545867</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Hereditary-Breast-Ovarian-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, BRCA1 and BRCA2 Pathogenic Variants (Hereditary Breast and Ovarian Cancer), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg164</URL>
                <CitationText>UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2024">
                <URL>https://www.nice.org.uk/guidance/ng101</URL>
                <CitationText>UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2024</CitationText>
              </Citation>
              <XRef ID="227535" DB="Orphanet" />
              <XRef ID="C0346153" DB="MedGen" />
              <XRef ID="MONDO:0016419" DB="MONDO" />
              <XRef Type="MIM" ID="114480" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23342" SubmissionDate="2015-07-01" DateLastUpdated="2015-07-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607585.0026_ATAXIA-TELANGIECTASIA" title="ATM, 4-BP DEL, IVS20_ATAXIA-TELANGIECTASIA" />
        <ClinVarAccession Accession="SCV000023342" DateUpdated="2015-07-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Pagani et al. (2002) found an unusual type of mutation in the ATM gene causing ataxia-telangiectasia (AT; 208900). The patient was a 20-year-old male of German-Polish descent who suffered from cerebellar ataxia, immunodeficiency, and cellular radiosensitivity. He was a compound heterozygote with respect to both a 2250G-A splicing mutation that caused complete skipping of exon 16 and an intron deletion that caused a cryptic exon inclusion between exons 20 and 21. No other mutation had been identified in a previous sequencing analysis of all exons of ATM in his genomic DNA (Sandoval et al., 1999). The deletion involved 4 nucleotides (GTAA) in intron 20 and resulted in the aberrant inclusion of a cryptic exon of 65 bp. The deletion was located 12 bp downstream and 53 bp upstream from the 5-prime and 3-prime ends of the cryptic exon, respectively. Through analysis of the splicing defect using a hybrid minigene system, Pagani et al. (2002) identified a new intron-splicing processing element (ISPE) complementary to U1 snRNA (180680), the RNA component of the U1 small nuclear ribonucleoprotein (snRNP). They found that the element mediates accurate intron processing and interacts specifically with U1 snRNP particles. The 4-nucleotide deletion completely abolished this interaction, causing activation of the cryptic exon. On the basis of the analysis in this instructive case, Pagani et al. (2002) described a new type of U1 snRNP binding site in an intron that is essential for accurate intron removal. Deletion of this sequence is directly involved in the splicing processing defect.</Attribute>
              <Citation>
                <ID Source="PubMed">11889466</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9887333</ID>
              </Citation>
              <XRef DB="OMIM" ID="208900" Type="MIM" />
              <XRef DB="OMIM" ID="180680" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Eng et al. (2004) referred to this type of mutation as a pseudoexon insertion and in a discussion of nonclassic splicing mutations in ataxia-telangiectasia patients referred to this as type II. They described 4 patients of diverse ethnicity with the mutation IVS20-579delAAGT and found that they all shared a common founder haplotype.</Attribute>
              <Citation>
                <ID Source="PubMed">14695534</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <Name>ATM, 4-BP DEL, IVS20</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, IVS20</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607585.0026" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ATAXIA-TELANGIECTASIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4890786" SubmissionDate="2022-04-19" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000051.3:c.2839-579_2839-576delAAGT|MedGen:C0004135" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002500162" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31611883</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Comment>Variant summary: ATM c.2839-579_2839-576delAAGT is located at a position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: two predict the variant weakens a cryptic 5 prime donor site; two predict the variant abolishes a 5 prime splicing donor site. However, at least one publication reports experimental evidence that this variant affects mRNA splicing. The variant was absent in 152078 control chromosomes. c.2839-579_2839-576delAAGT has been reported in the literature in individuals affected with Ataxia-Telangiectasia. These data indicate that the variant may be associated with disease. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2839-579_2839-576delAAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004135" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8045626" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkeNPPKgZxrrTcNtRfy-oxT4|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004361578" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22213089</ID>
          </Citation>
          <Comment>This variant causes a 4 base-pair deletion in intron 18 of the ATM gene and is described in the literature as 'a deletion of 4 bp (GTAA) in intron 20' (numbering based on the U33841 transcript) and 'IVS20-579del-AAGT'. RNA studies have shown that this variant disrupts a non-canonical U1 small nuclear ribonucleoprotein binding site resulting in the insertion of a 65 base-pair cryptic exon, which is predicted to cause a frameshift and premature stop codon (PMID: 11889466, 12815592, 14695534, 19773425). An allele-specific RT-PCR assay using cells from a carrier individual has shown that the mutant allele does not produce normal transcript (PMID: 11889466). This variant has been reported in the compound heterozygous state in individuals affected with ataxia telangiectasia (PMID: 11889466, 12815592, 14695534, 22213089). Lymphoblastoid cell lines derived from two of these individuals showed radiosensitivity and a significant reduction in protein expression (PMID: 14695534). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.4:c.2839-579_2839-576del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1547049" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="230169|OMIM:208900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000796746" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="G" referenceAllele="GGTAA" start="108141209" stop="108141213" variantLength="5" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2839-579_2839-576delAAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4958300" SubmissionDate="2022-04-25" DateLastUpdated="2022-06-24" DateCreated="2022-06-24">
        <ClinVarSubmissionID localKey="NM_000051.3:c.2839-579_2839-576del|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002532885" DateUpdated="2022-06-24" DateCreated="2022-06-24" Type="SCV" Version="1" SubmitterName="Sema4, Sema4" OrgID="500057" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9887333</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773425</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sema4 Curation Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/cy0kpury/sema4_variant_curation_guidelines-clinvar_april_2022.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2839-579_2839-576del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>The ATM c.2839-579_2839-576delAAGT variant has been reported as compound heterozygous in at least four individuals with ataxia telangiectasia (PMID: 11889466, 9887333, 14695534). Minigene splicing assays have shown that this variant activates a cryptic splice site, which results in the inclusion of 65 nucleotides of the intronic sequence in the mature RNA transcript (PMID: 11889466, 19773425). Patient cell lines have been shown to express very little or no ATM protein and colony survival assays indicated that the cells lines were radiosensitive (PMID: 14695534). It is also known as IVS20-579delAAGT in the literature. This variant is not reported in the Genome Aggregation Database (http://gnomad.broadinstitute.org, PMID: 32461654) but has been reported in ClinVar (Variation ID: 3043). Based on the current evidence available, this variant is interpreted as likely pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11360768</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7113032" SubmissionDate="2023-03-02" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="102490264|OMIM:114480" />
        <ClinVarAccession Accession="SCV003806576" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22213089</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Comment>This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 11889466, 12815592, 14695534, 22213089]. Functional studies indicate this variant impacts protein function [PMID: 11889466].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="11" alternateAllele="T" referenceAllele="TAAGT" start="108141211" stop="108141215" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102490264</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114480" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12928675</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3492959" SubmissionDate="2023-08-30" DateLastUpdated="2023-08-31" DateCreated="2021-08-12">
        <ClinVarSubmissionID localKey="GDXSV:285567" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001778845" DateUpdated="2023-08-31" DateCreated="2021-08-12" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Non-canonical splice site variant demonstrated to result in loss-of-function (Pagani et al., 2002; Kim et al., 2023); No data available from control populations to assess the frequency of this variant; Also known as IVS20-579delAAGT or IVS20-579_IVS20-576delAAGT; This variant is associated with the following publications: (PMID: 19823873, 19773425, 14695534, 31611883, 11889466, 22213089, 12815592, 37438524)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="11" alternateAllele="-" referenceAllele="AAGT" start="108141212" stop="108141215" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2096180</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_150_20221214054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_214_20230830054203</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_21_20210809104732</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2399979" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4073714|MedGen:C0004135" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001234323" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773425</ID>
          </Citation>
          <Comment>This sequence change falls in intron 18 of the ATM gene. It does not directly change the encoded amino acid sequence of the ATM protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with ataxia-telangiectasia (PMID: 11889466, 14695534; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as a deletion of 4 bp (GTAA) in intron 20, IVS20+1874delGTAA, and IVS20-579delAAGT. ClinVar contains an entry for this variant (Variation ID: 3043). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 11889466, 14695534, 19773425; Invitae). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.108141210_108141213del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004135" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2317530" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="a150037|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001177540" DateUpdated="2024-05-01" DateCreated="2020-03-16" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11889466</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12815592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14695534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19773425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9887333</ID>
          </Citation>
          <Comment>The c.2839-579_2839-576delAAGT intronic pathogenic mutation, located in intron 17 of the ATM gene, results from a deletion of 4 nucleotides within intron 17 of the ATM gene. This variant has been identified in multiple patients with Ataxia Telangiectasia in a compound heterozygous state with other pathogenic ATM variants; cell lines derived from these patients showed radiosensitivity and low or no detectable ATM protein (Mitui M et al. Hum. Mutat., 2003 Jul;22:43-50; Eng L et al. Hum. Mutat., 2004 Jan;23:67-76; Pagani F et al. Nat. Genet., 2002 Apr;30:426-9; Pastor T et al. Nucleic Acids Res., 2009 Nov;37:7258-67). This variant results in the inclusion of 65 nucleotides of intron 17 leading to a predicted frameshift and premature termination codon (Pagani F et al. Nat. Genet., 2002 Apr;30:426-9; Eng L et al. Hum. Mutat., 2004 Jan;23:67-76). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.3:c.2839-579_2839-576delAAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9793103" SubmissionDate="2024-05-21" DateLastUpdated="2024-05-26" DateCreated="2024-05-26">
        <ClinVarSubmissionID localKey="variant:8382962" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005044894" DateUpdated="2024-05-26" DateCreated="2024-05-26" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001271" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001310" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001336" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0001761" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002066" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002080" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002650" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0003202" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="11" alternateAllele="G" referenceAllele="GGTAA" start="108270482" stop="108270486" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">307772293</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14464990</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7853729" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000051.4:c.2839-579_2839-576del|OMIM:114480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004210079" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000051.4:c.2839-579_2839-576del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114480" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001310" MappingRef="HP">
        <MedGen CUI="C0234162" Name="Dysmetria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0003202" MappingRef="HP">
        <MedGen CUI="C0541794" Name="Muscular atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2317530" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7113032" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM">
        <MedGen CUI="C0346153" Name="Familial cancer of breast" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002080" MappingRef="HP">
        <MedGen CUI="C4551520" Name="Intention tremor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2399979" TraitType="Disease" MappingType="XRef" MappingValue="C0004135" MappingRef="MedGen">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001336" MappingRef="HP">
        <MedGen CUI="C0027066" Name="Myoclonus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4958300" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002650" MappingRef="HP">
        <MedGen CUI="C0036439" Name="Scoliosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001761" MappingRef="HP">
        <MedGen CUI="C0728829" Name="Pes cavus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23342" TraitType="Disease" MappingType="Name" MappingValue="ATAXIA-TELANGIECTASIA" MappingRef="Preferred">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="208900" MappingRef="OMIM">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1547049" TraitType="Disease" MappingType="XRef" MappingValue="208900" MappingRef="OMIM">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8045626" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3492959" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001271" MappingRef="HP">
        <MedGen CUI="C0152025" Name="Polyneuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9793103" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002066" MappingRef="HP">
        <MedGen CUI="C0751837" Name="Gait ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7853729" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM">
        <MedGen CUI="C0346153" Name="Familial cancer of breast" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4890786" TraitType="Disease" MappingType="XRef" MappingValue="C0004135" MappingRef="MedGen">
        <MedGen CUI="C0004135" Name="Ataxia-telangiectasia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

